Hims & Hers (HIMS -6.77%) is disrupting the healthcare market with its innovative patient treatment approach.
*Stock prices used were the afternoon prices of Nov. 13, 2024. The video was published on Nov. 15, 2024.
Free Article
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Should You Buy Hims & Hers Stock on the Dip?
By Parkev Tatevosian, CFA
–
Nov 15, 2024 at 7:19PM
NYSE: HIMS
Hims & Hers Health
Market Cap
$6B
Today's Change
(-6.77%) -$1.93
Current Price
$26.56
Price as of December 27, 2024, 4:00 p.m. ET
Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
Related Articles
Why Hims & Hers Stock Jumped on Massive FDA News
Hims & Hers New Growth Category Is a Huge Surprise
Hims & Hers Stock Is Down 30% This Week: Here's What Happened
Up 298% in a Year, Is Hims & Hers Still a Buy?
After Another Blowout Quarter of Surging Revenue, Is Hims & Hers Stock a Once-in-a-Decade Buy?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.